Former Venture Capitalist Prediction: Starlink Is Preparing a “Radical Change to Wi-Fi and the Internet Itself” Altucher Points to Private Meeting, Global Satellite Network, and a System Designed to Deliver Internet “At All Times” GlobeNewswire November 24, 2025 Washington, D.C., Nov. 24, 2025 (GLOBE NEWSWIRE) — Bestselling author and technology analyst James Altucher says new […]

Dare Bioscience Receives $3.6 Million in Additional Grant Funding Grant funding will support continued progress on a preclinical research program to identify and develop a non-hormonal intravaginal contraceptive innovation aimed at addressing unmet global needs GlobeNewswire November 24, 2025 SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) — DareÌ Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health

Monster Beverage Announces Webcast Details for Investor Meeting December 2, 2025; Company Announces Participation in Morgan Stanley Global Consumer & Retail Conference GlobeNewswire November 24, 2025 CORONA, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — Monster Beverage Corporation (NASDAQ: MNST) announced today that its Chief Executive Officer, Hilton Schlosberg (the “CEO“), and members of its senior

Hollister and Taco Bell Turn Y2K Nostalgia into the Season's Spiciest Drop The debut collaboration delivers a limited-edition capsule collection blending nostalgia, craveable comfort and style GlobeNewswire November 24, 2025 NEW ALBANY, Ohio, Nov. 24, 2025 (GLOBE NEWSWIRE) — Hollister Co. (“Hollister”), a brand of Abercrombie & Fitch Co. (NYSE: ANF), and Taco Bell are

Iterum Therapeutics Provides Business Update GlobeNewswire November 24, 2025 DUBLIN, Ireland and CHICAGO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today provided

Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference GlobeNewswire November 24, 2025 REDWOOD CITY, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will participate in

GigaCloud Technology Inc to Participate in UBS Global Technology and AI Conference GlobeNewswire November 24, 2025 EL MONTE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced that Larry Wu, it's Founder and Chief

Cerevance to Highlight Potential of Solengepras in Parkinson's Disease at the 2025 Parkinson Study Group Annual Meeting GlobeNewswire November 24, 2025 New findings from Phase 2 adjunctive study evaluating the characteristics of OFF time improvement with solengepras, a novel, non-dopaminergic GPR6 inhibitor; poster selected as one of 10 featured selections for the Poster Tour Results

LB Pharmaceuticals Announces Presentation at the Piper Sandler 37th Annual Healthcare Conference GlobeNewswire November 24, 2025 NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that Heather Turner, Chief Executive Officer, will present at the Piper Sandler 37th Annual Healthcare Conference in New York,

ASML reports transactions under its current share buyback program GlobeNewswire November 24, 2025 ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average price Total repurchased value 17-Nov-25 41,310 EUR875.57 EUR36,169,801